BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190501
DTEND;VALUE=DATE:20190505
DTSTAMP:20260729T201402
CREATED:20190414T083535Z
LAST-MODIFIED:20190414T084238Z
UID:21194-1556668800-1557014399@ces.b2sg.org
SUMMARY:Chromatin and Epigenetics
DESCRIPTION:Conference Overview\nEpigenetics refers to heritable change in gene expression that does not involve changes to the underlying DNA sequence. At least three systems including DNA methylation\, histone modifications and non-coding RNAs (ncRNA) are considered to play fundamental roles in epigenetic regulation. Research over the last two decades has uncovered the role of epigenetics in a variety of human disorders and fatal diseases. Moreover influence of age\, environment\, lifestyle\, and disease state on epigenetic states is being increasingly appreciated and actively studied. \nThis conference provides an international forum for cutting edge research in chromatin and epigenetics. It provides the “focal hub” for people to present their research and exchange ideas in a European venue. Renowned speakers will cover the latest advances in the field\, including chromatin regulation\, chromatin dynamics\, signalling to chromatin\, nuclear architecture and dynamics\, developmental epigenetics\, epigenomics\, epigenetics and human diseases\, genome stability\, environmental epigenetics\, and transgenerational inheritance. \nSession Topics\n\nEpigenetic reprogramming\nDevelopmental epigenetics\nDifferent states of chromatin\nHistone modifications\, RNA and metabolism\nTranscriptional and posttranscriptional regulation\nNuclear architecture\nChromatin and its variants in disease\n\nSpeakers: \nAsifa Akhtar\nMax Planck Institute of Immunobiology and Epigenetics\, Germany \nGeneviève Almouzni\nInstitut Curie\, France \nWendy Bickmore\nThe University of Edinburgh\, UK \nAndrea Brand\nThe Gurdon Institute\, University of Cambridge\, UK \nHoward Y. Chang\nStanford University\, USA \nL. Stirling Churchman\nHarvard Medical School\, USA \nIbrahim Cissé\nMassachusetts Institute of Technology\, USA \nXavier Darzacq\nUniversity of California\, Berkeley\, USA \nCaroline Dean\nJohn Innes Centre\, UK \nJoseph R. Ecker\nHHMI & The Salk Institute for Biological Studies\, USA \nEmma Farley\nUniversity of California\, San Diego\, USA \nAnne Ferguson-Smith\nUniversity of Cambridge\, UK \nPolly Fordyce\nStanford University\, USA \nEileen Furlong\nEMBL Heidelberg\, Germany \nEdith Heard\nEMBL Heidelberg\, Germany \nSteven Henikoff\nFred Hutchinson Cancer Research Center\, USA \nGary H. Karpen\nUC Berkeley\, Lawrence Berkeley National Lab\, USA \nJean-Christophe Marine\nVIB-KU Leuven Center for Cancer Biology\, Belgium \nAna Pombo\nMax Delbrück Center for Molecular Medicine\, Germany \nChris Ponting\nThe University of Edinburgh\, UK \nWolf Reik\nBabraham Institute\, UK \nAmos Tanay\nWeizmann Institute of Science\, Israel \nIgor Ulitsky\nWeizmann Institute of Science\, Israel \nFred Winston\nHarvard Medical School\, USA
URL:https://ces.b2sg.org/event/embo-meeting1may19/
LOCATION:EMBL Heidelberg\, Meyerhofstraße 1\, Heidelberg\, 69117 \, Germany
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/EMBO_Logo_grey-1.jpg
END:VEVENT
END:VCALENDAR